Anzup Cancer Trials Group Limited

About

Anzup Cancer Trials Group Limited is a multidisciplinary cancer cooperative trials group dedicated to improving the lives of individuals affected by 'below the belt' cancers, including bladder, kidney, testicular, penile, and prostate cancers. They achieve this by conducting high-quality, practice-changing multidisciplinary collaborative clinical trials in Australia and New Zealand.

Giving Philosophy

ANZUP's philosophy centers on improving outcomes for people with urogenital cancers by generating evidence through clinical trials. They actively identify critical areas of unmet need, collaborate with leading clinicians, scientists, and consumers, and prioritize research that leads to better treatments, improved quality of life, and reduced side effects for patients. They also foster new research ideas through seed funding and aim for independence from external grant uncertainties.

Tips for Applicants

Applicants for ANZUP's research grants, particularly the Below the Belt Research Fund, should focus on investigator-initiated studies that address critical clinical questions in urogenital cancers. Proposals should highlight innovative ideas with the potential to impact patient outcomes, including quality of life and reduced side effects. Emphasize how the research fills gaps where traditional government or industry funding might not be available.

Notable Grants

• Seed funding to A/Prof Weranja Ranasinghe in 2024 for work on evaluating the BCG-R5 immune marker in bladder cancer.
• Seed funding for pathways to assist informed decision-making in cancer treatment.
• Seed funding for a pilot of personalized hormone treatment for men with prostate cancer.
• Seed funding for assessing the benefit of irrigation with water after bladder cancer removal to reduce recurrence.
• Seed funding for an app enabling patients to record symptoms in real-time for clinic review.

Financial History (7 years)